Commemorating its 60th anniversary, Lamborghini unveiled a new concept supercar dubbed the Revuelto "Opera Unica" at Art Basel Miami Beach. Lamborghini CEO Stephan Winkelmann joined Yahoo Finance Live to discuss the one-off model's origins and significance. Winkelmann described the Revuelto-based Opera Unica as "very special," created specifically to celebrate Lamborghini crossing the 60-year milestone. The hand-painted EV features V12 hybrid powertrain technology along with styling cues paying homage to the 60th anniversary Lamborghini silhouette. Yahoo Finance hosts Josh Lipton and Pras Subramanian explore the Opera Unica's role as an anniversary centerpiece model, discussing Lamborghini demand trends with Winkelmann as markets recover post-COVID. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Commemorating its 60th anniversary, Lamborghini unveiled a new concept supercar dubbed the Revuelto "Opera Unica" at Art Basel Miami Beach. Lamborghini CEO Stephan Winkelmann joined Yahoo Finance Live to discuss the one-off model's origins and significance.
Winkelmann described the Revuelto-based Opera Unica as "very special," created specifically to celebrate Lamborghini crossing the 60-year milestone. The hand-painted EV features V12 hybrid powertrain technology along with styling cues paying homage to the 60th anniversary Lamborghini silhouette.
Yahoo Finance hosts Josh Lipton and Pras Subramanian explore the Opera Unica's role as an anniversary centerpiece model, discussing Lamborghini demand trends with Winkelmann as markets recover post-COVID.
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Reuters
It marks the second large deal for AbbVie in the past week, coming days after it agreed to buy cancer drug developer ImmunoGen for $10.1 billion in cash, highlighting its appetite to place big bets on promising new medicines. It is paying $45 per share in cash for Cerevel, which is developing drugs for Alzheimer's, Parkinson's, psychosis, epilepsy, and panic disorder. Its experimental drug emraclidine is in midstage trials as a treatment for schizophrenia that will yield data the company hopes can be used to seek regulatory approval.
Benzinga
On Tuesday, Nio Inc (NYSE: NIO) reported a narrower-than-expected third quarter loss. Like other automakers in China, Nio was pressured to slash prices, thinning its margins, in response to the price war that Tesla Inc (NASDAQ: TSLA) ignited at the beginning of the year. Nio’s Third Quarter Highlights Nio reported revenue below estimates of 19.4 billion yuan as sales amounted to 19.1 billion Chinese yuan which is about $2.7 billion. On the bright side, revenue rose 47% YoY. Unfortunately, Nio st
Bloomberg
(Bloomberg) -- Advanced Micro Devices Inc., taking aim at a burgeoning market dominated by Nvidia Corp., unveiled new so-called accelerator chips that it said will be able to run artificial intelligence software faster than rival products.Most Read from BloombergApple Readies New iPads and M3 MacBook Air to Combat Sales SlumpGlobal Bonds Power Ahead as Dovish Bets Take Hold: Markets WrapBiden Says He Might Not Have Sought Reelection If Trump Weren’t RunningKevin McCarthy Leaving House Months Aft
TechCrunch
Google's long-promised, next-gen generative AI model, Gemini, has arrived. Sort of. The version of Gemini launching this week, Gemini Pro, is essentially a lightweight offshoot of a more powerful, capable Gemini model set to arrive... sometime next year. But I'm getting ahead of myself. Yesterday in a virtual press briefing, members of the Google DeepMind team -- the driving force behind Gemini, alongside Google Research -- gave a high-level overview of Gemini (technically "Gemini 1.0") and its
Benzinga
Many people have turned to annuities as a reliable means of securing a stable income during retirement. Financial advisers often highlight annuities as a prudent choice for those looking to manage retirement finances effectively. With a $150,000 annuity, the monthly income potential varies based on several key factors, such as the type of annuity chosen, the age of the annuitant and the length of the payout period. Annuities, which are financial products offered by insurance companies, serve as
TipRanks
This has been a good year for stocks, no doubt about that. The S&P 500 has gained 19% year-to-date, after a gangbusters November, and the outlook for December, while more moderate, remains positive. The markets have made these gains despite a strong set of headwinds, including the Federal Reserve’s turn to a policy of aggressive monetary tightening and interest rate hikes; the ongoing war in Ukraine; and now the flare-up of war in the Middle East. This stock rally is showing real strength, and t
Read more --->